Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 204–204 | Cite as

Ipilimumab/peginterferon-α/pembrolizumab

Retinopathy and panhypopituitarism: case report
Case report
  • 4 Downloads

Reference

  1. Goto H, et al. Panhypopituitarism in metastatic melanoma patient treated with ipilimumab and pembrolizumab. Journal of Cutaneous Immunology and Allergy 2: 60-61, No. 2, Apr 2019. Available from: URL: http://doi.org/10.1002/cia2.12052 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations